This autumn, the Liege-based company Cefaly will launch a new field of application for its anti-migraine device: the TDCS (Transcranial Direct Current Stimulation). This will stimulate the brains of patients who have come out of a coma with the electrodes of the Cefaly, in order to improve their neurological recovery and increase their odds of returning to a state of consciousness.
Cefaly® is the world's first external neurostimulation device for treating and preventing migraines and headaches. Invented by the eponymous Liege-based SME and produced entirely in Wallonia, this device has been entering more and more markets.
"The new use of the Cefaly for comatose patients will strengthen our credibility", explains Pierre Rigaud, CEO and founder of the company.
The TDCS, a stimulation of the brain using the electrodes of the anti-migraine Cefaly headband, will allow patients who have come out of a coma to communicate with their family and medical staff. The device will initially only be sold in Europe, and then in the United States.
In 2016, Cefaly achieved sales of its products worth €5.011 million.
Source: L’Echo
